Metabolic Reprogramming and Renal Fibrosis

There are several causes of chronic kidney disease, but all of these patients have renal fibrosis. Although many studies have examined the pathogenesis of renal fibrosis, there are still no effective treatments. A healthy and balanced metabolism is necessary for normal cell growth, proliferation, an...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Xiaoyu Zhu, Lili Jiang, Mengtuan Long, Xuejiao Wei, Yue Hou, Yujun Du
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/40ac0209e09a45a1b591bd64b0f3a992
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:40ac0209e09a45a1b591bd64b0f3a992
record_format dspace
spelling oai:doaj.org-article:40ac0209e09a45a1b591bd64b0f3a9922021-11-08T08:02:44ZMetabolic Reprogramming and Renal Fibrosis2296-858X10.3389/fmed.2021.746920https://doaj.org/article/40ac0209e09a45a1b591bd64b0f3a9922021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fmed.2021.746920/fullhttps://doaj.org/toc/2296-858XThere are several causes of chronic kidney disease, but all of these patients have renal fibrosis. Although many studies have examined the pathogenesis of renal fibrosis, there are still no effective treatments. A healthy and balanced metabolism is necessary for normal cell growth, proliferation, and function, but metabolic abnormalities can lead to pathological changes. Normal energy metabolism is particularly important for maintaining the structure and function of the kidneys because they consume large amounts of energy. We describe the metabolic reprogramming that occurs during renal fibrosis, which includes changes in fatty acid metabolism and glucose metabolism, and the relationship of these changes with renal fibrosis. We also describe the potential role of novel drugs that disrupt this metabolic reprogramming and the development of fibrosis, and current and future challenges in the treatment of fibrosis.Xiaoyu ZhuLili JiangMengtuan LongXuejiao WeiYue HouYujun DuFrontiers Media S.A.articlerenal fibrosischronic kidney diseasemetabolic reprogrammingfatty acidaerobic glycolysisMedicine (General)R5-920ENFrontiers in Medicine, Vol 8 (2021)
institution DOAJ
collection DOAJ
language EN
topic renal fibrosis
chronic kidney disease
metabolic reprogramming
fatty acid
aerobic glycolysis
Medicine (General)
R5-920
spellingShingle renal fibrosis
chronic kidney disease
metabolic reprogramming
fatty acid
aerobic glycolysis
Medicine (General)
R5-920
Xiaoyu Zhu
Lili Jiang
Mengtuan Long
Xuejiao Wei
Yue Hou
Yujun Du
Metabolic Reprogramming and Renal Fibrosis
description There are several causes of chronic kidney disease, but all of these patients have renal fibrosis. Although many studies have examined the pathogenesis of renal fibrosis, there are still no effective treatments. A healthy and balanced metabolism is necessary for normal cell growth, proliferation, and function, but metabolic abnormalities can lead to pathological changes. Normal energy metabolism is particularly important for maintaining the structure and function of the kidneys because they consume large amounts of energy. We describe the metabolic reprogramming that occurs during renal fibrosis, which includes changes in fatty acid metabolism and glucose metabolism, and the relationship of these changes with renal fibrosis. We also describe the potential role of novel drugs that disrupt this metabolic reprogramming and the development of fibrosis, and current and future challenges in the treatment of fibrosis.
format article
author Xiaoyu Zhu
Lili Jiang
Mengtuan Long
Xuejiao Wei
Yue Hou
Yujun Du
author_facet Xiaoyu Zhu
Lili Jiang
Mengtuan Long
Xuejiao Wei
Yue Hou
Yujun Du
author_sort Xiaoyu Zhu
title Metabolic Reprogramming and Renal Fibrosis
title_short Metabolic Reprogramming and Renal Fibrosis
title_full Metabolic Reprogramming and Renal Fibrosis
title_fullStr Metabolic Reprogramming and Renal Fibrosis
title_full_unstemmed Metabolic Reprogramming and Renal Fibrosis
title_sort metabolic reprogramming and renal fibrosis
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/40ac0209e09a45a1b591bd64b0f3a992
work_keys_str_mv AT xiaoyuzhu metabolicreprogrammingandrenalfibrosis
AT lilijiang metabolicreprogrammingandrenalfibrosis
AT mengtuanlong metabolicreprogrammingandrenalfibrosis
AT xuejiaowei metabolicreprogrammingandrenalfibrosis
AT yuehou metabolicreprogrammingandrenalfibrosis
AT yujundu metabolicreprogrammingandrenalfibrosis
_version_ 1718442799543615488